| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accessing opiate dependence treatment medications: buprenorphine products in an office-based setting
|
Leshner, Alan I.
|
|
2003
|
|
2S |
p. S103-S104
2 p.
|
artikel
|
| 2 |
Buprenorphine: how to use it right
|
Johnson, Rolley E.
|
|
2003
|
|
2S |
p. S59-S77
19 p.
|
artikel
|
| 3 |
Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?
|
Mendelson, John
|
|
2003
|
|
2S |
p. S29-S37
9 p.
|
artikel
|
| 4 |
Clinical efficacy of buprenorphine: comparisons to methadone and placebo
|
Ling, Walter
|
|
2003
|
|
2S |
p. S49-S57
9 p.
|
artikel
|
| 5 |
Editorial Board
|
|
|
2003
|
|
2S |
p. IFC-
1 p.
|
artikel
|
| 6 |
Foreword to: Buprenorphine and buprenorphine/naloxone: a guide for clinicians
|
Fudala, Paul J.
|
|
2003
|
|
2S |
p. S1-S2
2 p.
|
artikel
|
| 7 |
From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States
|
Jaffe, Jerome H.
|
|
2003
|
|
2S |
p. S3-S11
9 p.
|
artikel
|
| 8 |
Pharmacokinetics of the combination tablet of buprenorphine and naloxone
|
Chiang, C.Nora
|
|
2003
|
|
2S |
p. S39-S47
9 p.
|
artikel
|
| 9 |
Safety and health policy considerations related to the use of buprenorphine/naloxone as an office-based treatment for opiate dependence
|
Bridge, T.Peter
|
|
2003
|
|
2S |
p. S79-S85
7 p.
|
artikel
|
| 10 |
The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic
|
Walsh, Sharon L
|
|
2003
|
|
2S |
p. S13-S27
15 p.
|
artikel
|
| 11 |
Use of buprenorphine in pregnancy: patient management and effects on the neonate
|
Johnson, Rolley E.
|
|
2003
|
|
2S |
p. S87-S101
15 p.
|
artikel
|
Tijdschrift beschrijving